Abstract Breast cancer is the most common malignant neoplasm among women and exhibits high molecular heterogeneity, which directly influences therapeutic response and clinical outc
A descriptive comparative analysis of guideline recommendations, utilization patterns, and research directions without primary efficacy or safety outcome data; provides context on current practice but no new clinical evidence.